ATA194780A - Verfahren zur herstellung von stabilen injektionspraeparaten zur parenteralen verabreichung mit einem gehalt an indol_ oder indanessigsaeurederivaten - Google Patents

Verfahren zur herstellung von stabilen injektionspraeparaten zur parenteralen verabreichung mit einem gehalt an indol_ oder indanessigsaeurederivaten

Info

Publication number
ATA194780A
ATA194780A AT0194780A AT194780A ATA194780A AT A194780 A ATA194780 A AT A194780A AT 0194780 A AT0194780 A AT 0194780A AT 194780 A AT194780 A AT 194780A AT A194780 A ATA194780 A AT A194780A
Authority
AT
Austria
Prior art keywords
indol
production
content
acid derivatives
parenteral administration
Prior art date
Application number
AT0194780A
Other languages
English (en)
Other versions
AT369650B (de
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Publication of ATA194780A publication Critical patent/ATA194780A/de
Application granted granted Critical
Publication of AT369650B publication Critical patent/AT369650B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A61K47/544—Phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT0194780A 1979-04-11 1980-04-10 Verfahren zur herstellung von stabilen injektionspraeparaten zur parenteralen verabreichung mit einem gehalt an indol- oder indanessigsaeurederivaten AT369650B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792914789 DE2914789A1 (de) 1979-04-11 1979-04-11 Injizierbare arzneimittel mit entzuendungshemmender wirkung

Publications (2)

Publication Number Publication Date
ATA194780A true ATA194780A (de) 1982-06-15
AT369650B AT369650B (de) 1983-01-25

Family

ID=6068138

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0194780A AT369650B (de) 1979-04-11 1980-04-10 Verfahren zur herstellung von stabilen injektionspraeparaten zur parenteralen verabreichung mit einem gehalt an indol- oder indanessigsaeurederivaten

Country Status (14)

Country Link
US (1) US4309420A (de)
JP (1) JPS55147217A (de)
AT (1) AT369650B (de)
AU (1) AU539043B2 (de)
BE (1) BE882732A (de)
CA (1) CA1136048A (de)
CH (1) CH642547A5 (de)
DE (1) DE2914789A1 (de)
FR (1) FR2453646A1 (de)
GB (1) GB2047535B (de)
IT (1) IT1148791B (de)
NL (1) NL8002096A (de)
SE (1) SE451428B (de)
ZA (1) ZA802158B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3042365C2 (de) * 1980-11-10 1987-01-29 Extrakta Strauss GmbH, 2000 Hamburg Flüssige, lecithinhaltige einphasige Mehrstoffsysteme und Verfahren zu ihrer Herstellung
JPS59152348A (ja) * 1983-02-19 1984-08-31 Kaken Pharmaceut Co Ltd ビフエニリルプロピオン酸エステル誘導体およびその製造法
US5196567A (en) * 1983-02-19 1993-03-23 Kaken Pharmaceutical Co., Ltd. Biphenylylpropionic acid derivative, process for preparing the same and pharmaceutical composition containing the same
CA1237670A (en) * 1983-05-26 1988-06-07 Andrew S. Janoff Drug preparations of reduced toxicity
US5059591B1 (en) * 1983-05-26 2000-04-25 Liposome Co Inc Drug preparations of reduced toxicity
JPS601122A (ja) * 1983-06-20 1985-01-07 Green Cross Corp:The ビフエニリルプロピオン酸誘導体脂肪乳剤
PT78628B (en) * 1984-05-02 1986-06-18 Liposome Co Inc Pharmaceutical composition with reduced toxicity
IL79114A (en) * 1985-08-07 1990-09-17 Allergan Pharma Method and composition for making liposomes
IT1269569B (it) * 1994-04-22 1997-04-08 Ugo Citernesi Procedimento per la preparazione di complessi fra fosfolipidi e principi attivi utili per la produzione di liposomi e principi attivi e liposomi ottenuti con il procedimento
US5763422A (en) * 1995-01-27 1998-06-09 Board Of Regents, The University Of Texas System Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein
WO1996022780A1 (en) * 1995-01-27 1996-08-01 The Board Of Regents Of The University Of Texas System Methods of enhancing the therapeutic activity of nsaids and compositions of zwitterionic phospholipids useful therein
US5955451A (en) * 1995-05-12 1999-09-21 The University Of Texas System Board Of Regents Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein
US20040077604A1 (en) * 2001-12-19 2004-04-22 Lenard Lichtenberger Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providingenhanced therapeutic activity
EP2760433B1 (de) 2011-09-29 2023-05-31 PLx Opco Inc. Ph-abhängige träger zur gezielten freisetzung von pharmazeutika entlang den gastrointestinaltrakts, zusammensetzungen daraus sowie ihre herstellung und verwendung
JP2023518822A (ja) 2020-03-26 2023-05-08 ピーエルエックス オプコ インコーポレイテッド pH依存的再構築が可能な医薬キャリア、その製造方法及び使用方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA725596A (en) * 1960-08-26 1966-01-11 J. Wretlind Arvid Method of preparing intravenously injectable fat emulsions free from side reactions or complications
GB1214515A (en) * 1967-04-11 1970-12-02 Sumitomi Chemical Company Ltd Indole derivatives and salts thereof
JPS5186117A (en) * 1975-01-27 1976-07-28 Tanabe Seiyaku Co Johoseibiryushiseizainoseiho
GB1523965A (en) * 1976-03-19 1978-09-06 Ici Ltd Pharmaceutical compositions containing steroids
US4093733A (en) * 1976-09-09 1978-06-06 Merck & Co., Inc. Parenteral suspensions
GB1575343A (en) * 1977-05-10 1980-09-17 Ici Ltd Method for preparing liposome compositions containing biologically active compounds
DE2856333C2 (de) * 1978-12-27 1983-09-22 A. Nattermann & Cie GmbH, 5000 Köln Oral einnehmbare Arzneimittel mit entzündungshemmender Wirkung

Also Published As

Publication number Publication date
DE2914789C2 (de) 1991-05-29
AU539043B2 (en) 1984-09-06
DE2914789A1 (de) 1980-10-16
GB2047535A (en) 1980-12-03
BE882732A (fr) 1980-07-31
CA1136048A (en) 1982-11-23
US4309420A (en) 1982-01-05
GB2047535B (en) 1983-10-26
JPH0210805B2 (de) 1990-03-09
NL8002096A (nl) 1980-10-14
JPS55147217A (en) 1980-11-17
AU5733080A (en) 1980-10-16
SE8002715L (sv) 1980-10-12
SE451428B (sv) 1987-10-12
CH642547A5 (de) 1984-04-30
FR2453646A1 (fr) 1980-11-07
IT8021300A0 (it) 1980-04-10
IT1148791B (it) 1986-12-03
ZA802158B (en) 1981-05-27
AT369650B (de) 1983-01-25
FR2453646B1 (de) 1985-01-25

Similar Documents

Publication Publication Date Title
ATA195880A (de) Verfahren zur herstellung von stabilen injektions-praeparaten zur parenteralen verabreichung enthaltend aryl- bzw. heteroarylessigsaeure- bzw. aryl- bzw. heteroarylpropionsaeurederivate
AT384228B (de) Verfahren zur herstellung von neuen agmatinderivaten mit blutgerinnungshemmender wirkung
AT358818B (de) Verfahren zur herstellung von thiofunktionelle gruppen aufweisenden organopolysiloxanen
AT347922B (de) Verfahren zur herstellung von neuen benzoesaeuren, deren estern und salzen
AT361121B (de) Verfahren zur herstellung von neuen 7beta-aryl- malonamido-7alpha-methoxy-3-thiadiazolylthio-1- -oxadethiacephalosporinen und deren estern und salzen mit basen
AT369650B (de) Verfahren zur herstellung von stabilen injektionspraeparaten zur parenteralen verabreichung mit einem gehalt an indol- oder indanessigsaeurederivaten
AT358045B (de) Verfahren zur herstellung von neuen pyrimid-4- -on- und -thion-derivaten und ihrer salze mit saeuren
AT348995B (de) Verfahren zur herstellung von acylcyaniden
AT363591B (de) Verfahren zur herstellung von lebendimpfstoffen mit einem gehalt an stabilen, hochimmunogenen bakterienmutanten
DD128196A5 (de) Verfahren zur herstellung von clavulansaeure-thioaethern
DD133665A1 (de) Verfahren zur herstellung von estern
AT360149B (de) Verfahren zur herstellung einer injektions- zubereitung mit einem gehalt an chloramphenicol
DD128362A5 (de) Verfahren zur herstellung von benzylestern mit pestizidwirkung
AT363181B (de) Verfahren zur herstellung von neuen clavulansaeurederivaten
AT343398B (de) Verfahren zur herstellung von belastbaren rasenflachen
ATA220774A (de) Verfahren zur herstellung von lebensmitteln mit reduziertem energiegehalt
AT346869B (de) Verfahren zur herstellung von duengemitteln mit verzoegerter naehrstoffabgabe
DD133941A5 (de) Verfahren zur herstellung von estern der phenylaethylamine
DD138979A1 (de) Verfahren zur herstellung von acylthioharnstoffen mit ergolinstruktur
ATA216378A (de) Verfahren zur herstellung von zweiteiligen packungen mit einem gehalt an injizierbaren arzneipraeparaten
AT371117B (de) Verfahren zur herstellung von 2-methyl-3furancarbons[ureanilid
AT356269B (de) Verfahren zur herstellung von clavulansaeure- aethern
AT371417B (de) Verfahren zur herstellung von aktivkohle
DD137233A5 (de) Verfahren zur herstellung von komplexen mit asymmetrischen aminophosphinen
AT364839B (de) Verfahren zur elektrochemischen herstellung von 2-amino-2-aethylthiophen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
UEP Publication of translation of european patent specification